titan pharmaceuticals inc shares were down 53 to 108 premarket wednesday after the company said a 55 million registered direct and private investment in public equity offering priced titan said it entered into a securities purchase agreement with an institutional investor to purchase about 34 million shares of its common stock in a registered direct offering priced atthemarket in a concurrent private placement titan said it has also agreed to issue and sell to the investor about 13 million prefunded warrants at the same purchase price in addition the company said it has agreed to issue to the investor unregistered warrants to purchase up to an aggregate of about 47 million shares the combined offering price of each share or prefunded warrant and each warrant will be 118